Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis

dc.contributor.authorKalambokis, G.en
dc.contributor.authorTsiouris, S.en
dc.contributor.authorTsianos, E. V.en
dc.contributor.authorBaltayiannis, G.en
dc.contributor.authorPakou, B.en
dc.contributor.authorFotopoulos, A.en
dc.date.accessioned2015-11-24T19:20:28Z
dc.date.available2015-11-24T19:20:28Z
dc.identifier.issn1478-3231-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22041
dc.rightsDefault Licence-
dc.subjectEsophageal and Gastric Varices/drug therapy/etiology/physiopathologyen
dc.subjectFemaleen
dc.subjectGamma Camerasen
dc.subjectHemodynamics/drug effectsen
dc.subjectHormones/*therapeutic useen
dc.subjectHumansen
dc.subjectHypertension, Portal/complications/drug therapy/physiopathologyen
dc.subjectInfusions, Intravenousen
dc.subjectLiver Circulation/*drug effectsen
dc.subjectLiver Cirrhosis/complications/*drug therapy/physiopathologyen
dc.subjectLypressin/*analogs & derivatives/therapeutic useen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectRadiopharmaceuticals/diagnostic useen
dc.subjectSomatostatin/*therapeutic useen
dc.subjectTechnetium Tc 99m Sestamibi/diagnostic useen
dc.subjectThorax/*blood supply/radionuclide imagingen
dc.subjectVasoconstrictor Agents/*therapeutic useen
dc.titleEffects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosisen
heal.abstractBACKGROUND: Variceal bleeding in cirrhosis can cause liver ischaemia and deteriorate the hyperdynamic state; thus, the effects of vasoconstrictor therapy on liver blood volume (LBV) and thorax blood volume (ThBV) are important. AIM: To evaluate and compare the effects of terlipressin and somatostatin on LBV and ThBV in stable patients with cirrhosis and portal hypertension. METHODS: Twenty patients were studied (Child-Pugh class A/B/C: 5/8/7). The radioactivities in the liver region (LRR) and the thorax region (ThRR) by single-head gamma camera technique, as indicators of LBV and ThBV, respectively, and systemic haemodynamics were measured at baseline and after intravenous infusion of 2 mg of terlipressin (n=10) or somatostatin 250 mg/h after an initial bolus of 250 mg (n=10). RESULTS: LRR and ThRR decreased significantly with increasing severity of cirrhosis. Thirty minutes after terlipressin infusion, LRR and ThRR increased by 7.8 +/- 4.4% (NS) and 14 +/- 5.3% (P=0.01) compared with baseline values; the increase in ThRR was significantly related to the increase in LRR (r=0.682, P=0.03). In contrast, somatostatin reduced LRR and ThRR by 13.3 +/- 6.5% (P=0.07) and 1 +/- 4% (NS) respectively. LRR and ThRR increased significantly in the terlipressin group compared with the somatostatin group (P=0.01 and P=0.02 respectively). Terlipressin reduced cardiac output and heart rate (both P=0.01) and increased the mean arterial pressure (MAP) and systemic vascular resistance (P=0.009 and P=0.002 respectively); MAP decreased after somatostatin infusion (P=0.03). CONCLUSIONS: Terlipressin, but not somatostatin, maintains LBV, increases ThBV and improves the hyperdynamic state in cirrhosis. These effects can be beneficial in variceal bleeding, particularly in patients with advanced liver disease.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1111/j.1478-3231.2010.02322.x-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20738780-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1478-3231.2010.02322.x/asset/j.1478-3231.2010.02322.x.pdf?v=1&t=h0ulxvka&s=4e5a272cc1b41389924c2d613433097c3ef15e36-
heal.journalNameLiver Inten
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: